No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals
Crossref DOI link: https://doi.org/10.1186/s13063-016-1447-5
Published Online: 2016-07-16
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gabler, Nicole B.
Duan, Naihua
Raneses, Eli
Suttner, Leah
Ciarametaro, Michael
Cooney, Elizabeth
Dubois, Robert W.
Halpern, Scott D.
Kravitz, Richard L.
Funding for this research was provided by:
National Pharmaceutical Council
License valid from 2016-07-16